These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8305216)

  • 1. Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy and biologic characterization of human tumors.
    Larson SM; Macapinlac HA; Scott AM; Divgi CR
    Acta Oncol; 1993; 32(7-8):709-15. PubMed ID: 8305216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
    Oriuchi N
    Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
    Britton KE
    Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
    Goldenberg DM
    Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models for radiolabeled monoclonal antibodies in cancer research.
    Aas M; Fjeld JG
    Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cancer with radiolabeled antibodies.
    Goldenberg DM; Larson SM; Reisfeld RA; Schlom J
    Immunol Today; 1995 Jun; 16(6):261-4. PubMed ID: 7662094
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of radiolabeled monoclonal antibodies for diagnosis and therapy of cancer.
    Divgi CR
    Oncology (Williston Park); 1996 Jun; 10(6):939-53; discussion 954, 957-8. PubMed ID: 8823804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
    Stipsanelli E; Valsamaki P
    Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunology. Imaging and therapy.
    Larson SM
    Cancer; 1991 Feb; 67(4 Suppl):1253-60. PubMed ID: 1991286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3rd Scandinavian Symposium on Radiolabeled Monoclonal Antibodies for Cancer Diagnosis and Therapy. Proceedings. Helsinki, Finland, October 30-31, 1992.
    Acta Oncol; 1993; 32(7-8):707-891. PubMed ID: 7905745
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumour imaging with radiolabelled monoclonal antibodies.
    Britton KE
    Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments.
    Carrasquillo JA; Krohn KA; Beaumier P; McGuffin RW; Brown JP; Hellström KE; Hellström I; Larson SM
    Cancer Treat Rep; 1984 Jan; 68(1):317-28. PubMed ID: 6607111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunotargeting of tumors: state of the art and prospects in 2000].
    Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I
    Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM; Sharkey RM; Juweid ME; Dunn RM; Ying Z; Zhang CH; Siegel JA; Goldenberg DM
    J Nucl Med; 1997 Mar; 38(3):409-18. PubMed ID: 9074529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radioimmunotherapy and chemotherapy of breast tumors with Y-90-labeled anti-Her2 and anti-CEA antibodies with taxol.
    Crow DM; Williams L; Colcher D; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2005; 16(5):1117-25. PubMed ID: 16173788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer imaging with radiolabeled antibodies: new advances with technetium-99m-labeled monoclonal antibody Fab' fragments, especially CEA-Scan and prospects for therapy.
    Goldenberg DM; Juweid M; Dunn RM; Sharkey RM
    J Nucl Med Technol; 1997 Mar; 25(1):18-23; quiz 34. PubMed ID: 9239599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological and clinical perspectives of cancer imaging and therapy with radiolabeled antibodies.
    Goldenberg DM; Blumenthal RD; Sharkey RM
    Semin Cancer Biol; 1990 Jun; 1(3):217-25. PubMed ID: 2103497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma, melanoma, colon cancer: diagnosis and treatment with radiolabeled monoclonal antibodies. The 1986 Eugene P. Pendergrass New Horizons Lecture.
    Larson SM
    Radiology; 1987 Nov; 165(2):297-304. PubMed ID: 3498971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.